Search Results

There are 7884587 results for: content related to: A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure

  1. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  2. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  3. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 791–801, Tim Moors, Silvia Paciotti, Davide Chiasserini, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari and Wilma D. J. van de Berg

    Version of Record online : 29 FEB 2016, DOI: 10.1002/mds.26562

  4. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  5. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide

    Movement Disorders

    Volume 28, Issue 9, August 2013, Pages: 1184–1199, Maria Stamelou, Niall P. Quinn and Kailash P. Bhatia

    Version of Record online : 29 MAY 2013, DOI: 10.1002/mds.25509

  6. Glycation in Parkinson's disease and Alzheimer's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 782–790, Hugo Vicente Miranda, Omar M. A. El-Agnaf and Tiago Fleming Outeiro

    Version of Record online : 4 MAR 2016, DOI: 10.1002/mds.26566

  7. Structural studies of parkin and sacsin: Mitochondrial dynamics in neurodegenerative diseases

    Movement Disorders

    Volume 30, Issue 12, October 2015, Pages: 1610–1619, Xinlu Li and Kalle Gehring

    Version of Record online : 11 SEP 2015, DOI: 10.1002/mds.26357

  8. The clinical spectrum of anxiety in Parkinson's disease

    Movement Disorders

    Volume 29, Issue 8, July 2014, Pages: 967–975, Nadeeka N.N.W. Dissanayaka, Elizabeth White, John D. O'Sullivan, Rodney Marsh, Nancy A. Pachana and Gerard J. Byrne

    Version of Record online : 17 JUL 2014, DOI: 10.1002/mds.25937

  9. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  10. The role of the cerebellum in the pathogenesis of cortical myoclonus

    Movement Disorders

    Volume 29, Issue 4, April 2014, Pages: 437–443, Christos Ganos, Panagiotis Kassavetis, Roberto Erro, Mark J. Edwards, John Rothwell and Kailash P. Bhatia

    Version of Record online : 14 MAR 2014, DOI: 10.1002/mds.25867

  11. Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon

    Movement Disorders

    Volume 28, Issue 11, 15 September 2013, Pages: 1509–1519, Alice Nieuwboer and Nir Giladi

    Version of Record online : 16 OCT 2013, DOI: 10.1002/mds.25683

  12. Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

    Movement Disorders

    Volume 28, Issue 10, September 2013, Pages: 1337–1342, Jose L. Labandeira-Garcia, Jannette Rodriguez-Pallares, Antonio Dominguez-Meijide, Rita Valenzuela, Begoña Villar-Cheda and Ana I. Rodríguez-Perez

    Version of Record online : 7 AUG 2013, DOI: 10.1002/mds.25614

  13. Early synaptic dysfunction in Parkinson's disease: Insights from animal models

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 802–813, Tommaso Schirinzi, Graziella Madeo, Giuseppina Martella, Marta Maltese, Barbara Picconi, Paolo Calabresi and Antonio Pisani

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26620

  14. Future of brain stimulation: New targets, new indications, new technology

    Movement Disorders

    Volume 28, Issue 13, November 2013, Pages: 1784–1792, Marwan Hariz, Patric Blomstedt and Ludvic Zrinzo

    Version of Record online : 7 OCT 2013, DOI: 10.1002/mds.25665

  15. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 771–781, Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola and Claudia Balducci

    Version of Record online : 31 MAR 2016, DOI: 10.1002/mds.26624

  16. You have free access to this content
    Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 848–860, Steffen Halbgebauer, Patrick Öckl, Katharina Wirth, Petra Steinacker and Markus Otto

    Version of Record online : 2 MAY 2016, DOI: 10.1002/mds.26635

  17. Emotional manifestations of PD: Neurobiological basis

    Movement Disorders

    Anna Castrioto, Stéphane Thobois, Sebastien Carnicella, Audrey Maillet and Paul Krack

    Version of Record online : 4 APR 2016, DOI: 10.1002/mds.26587

  18. You have free access to this content
    The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease

    Movement Disorders

    Volume 31, Issue 1, January 2016, Pages: 23–38, Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis and Alice Cronin-Golomb

    Version of Record online : 30 DEC 2015, DOI: 10.1002/mds.26484

  19. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies

    Movement Disorders

    Volume 31, Issue 2, February 2016, Pages: 178–192, Maria Xilouri, Oeystein Roed Brekk and Leonidas Stefanis

    Version of Record online : 27 JAN 2016, DOI: 10.1002/mds.26477

  20. Behavioral effects of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 90–102, Isabelle Beaulieu-Boire and Anthony E. Lang

    Version of Record online : 9 DEC 2014, DOI: 10.1002/mds.26121